nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—ABCB11—Rifampicin—leprosy	0.528	0.591	CbGbCtD
Bosentan—CYP2C9—Thalidomide—leprosy	0.0964	0.108	CbGbCtD
Bosentan—CYP2C9—Rifampicin—leprosy	0.0933	0.104	CbGbCtD
Bosentan—CYP2C9—Dapsone—leprosy	0.0771	0.0862	CbGbCtD
Bosentan—CYP3A4—Rifampicin—leprosy	0.0543	0.0607	CbGbCtD
Bosentan—CYP3A4—Dapsone—leprosy	0.0448	0.0501	CbGbCtD
Bosentan—Ascites—Thalidomide—leprosy	0.00302	0.0286	CcSEcCtD
Bosentan—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.00237	0.0224	CcSEcCtD
Bosentan—Toothache—Thalidomide—leprosy	0.00226	0.0214	CcSEcCtD
Bosentan—Intestinal obstruction—Thalidomide—leprosy	0.00202	0.0191	CcSEcCtD
Bosentan—Skin ulcer—Thalidomide—leprosy	0.00177	0.0167	CcSEcCtD
Bosentan—Nasopharyngitis—Dapsone—leprosy	0.00174	0.0165	CcSEcCtD
Bosentan—Influenza—Dapsone—leprosy	0.00168	0.0159	CcSEcCtD
Bosentan—Skin discolouration—Thalidomide—leprosy	0.00152	0.0144	CcSEcCtD
Bosentan—Bone disorder—Thalidomide—leprosy	0.00152	0.0144	CcSEcCtD
Bosentan—Sinusitis—Dapsone—leprosy	0.00141	0.0133	CcSEcCtD
Bosentan—Tinnitus—Dapsone—leprosy	0.00126	0.0119	CcSEcCtD
Bosentan—Pulmonary oedema—Thalidomide—leprosy	0.00122	0.0116	CcSEcCtD
Bosentan—Erythema—Dapsone—leprosy	0.00117	0.0111	CcSEcCtD
Bosentan—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00115	0.0109	CcSEcCtD
Bosentan—Gastroenteritis—Thalidomide—leprosy	0.00113	0.0106	CcSEcCtD
Bosentan—Eczema—Thalidomide—leprosy	0.00111	0.0105	CcSEcCtD
Bosentan—Vision blurred—Dapsone—leprosy	0.00111	0.0105	CcSEcCtD
Bosentan—Vertigo—Dapsone—leprosy	0.00105	0.00997	CcSEcCtD
Bosentan—Atrial fibrillation—Thalidomide—leprosy	0.00105	0.00996	CcSEcCtD
Bosentan—Cough—Dapsone—leprosy	0.00102	0.00969	CcSEcCtD
Bosentan—Hypoglycaemia—Thalidomide—leprosy	0.00102	0.00967	CcSEcCtD
Bosentan—Cardiac failure—Thalidomide—leprosy	0.00102	0.00967	CcSEcCtD
Bosentan—Lethargy—Thalidomide—leprosy	0.00102	0.00963	CcSEcCtD
Bosentan—Cerebrovascular accident—Thalidomide—leprosy	0.00102	0.00963	CcSEcCtD
Bosentan—Hyponatraemia—Thalidomide—leprosy	0.001	0.00948	CcSEcCtD
Bosentan—Pain in extremity—Thalidomide—leprosy	0.000998	0.00944	CcSEcCtD
Bosentan—Disturbance in sexual arousal—Thalidomide—leprosy	0.00099	0.00936	CcSEcCtD
Bosentan—Affect lability—Thalidomide—leprosy	0.000982	0.00929	CcSEcCtD
Bosentan—Cardiac arrest—Thalidomide—leprosy	0.000949	0.00897	CcSEcCtD
Bosentan—Mood swings—Thalidomide—leprosy	0.000945	0.00894	CcSEcCtD
Bosentan—Tachycardia—Dapsone—leprosy	0.000935	0.00884	CcSEcCtD
Bosentan—Dehydration—Thalidomide—leprosy	0.000928	0.00878	CcSEcCtD
Bosentan—Liver function test abnormal—Thalidomide—leprosy	0.000921	0.00871	CcSEcCtD
Bosentan—Dry skin—Thalidomide—leprosy	0.000915	0.00865	CcSEcCtD
Bosentan—Orthostatic hypotension—Thalidomide—leprosy	0.000911	0.00862	CcSEcCtD
Bosentan—Hypokalaemia—Thalidomide—leprosy	0.000908	0.00859	CcSEcCtD
Bosentan—Cramp muscle—Thalidomide—leprosy	0.000899	0.0085	CcSEcCtD
Bosentan—Abdominal distension—Thalidomide—leprosy	0.000868	0.00821	CcSEcCtD
Bosentan—Insomnia—Dapsone—leprosy	0.000867	0.0082	CcSEcCtD
Bosentan—Influenza—Thalidomide—leprosy	0.000862	0.00816	CcSEcCtD
Bosentan—Eosinophilia—Thalidomide—leprosy	0.000854	0.00808	CcSEcCtD
Bosentan—Bronchospasm—Thalidomide—leprosy	0.000848	0.00802	CcSEcCtD
Bosentan—Angina pectoris—Thalidomide—leprosy	0.00084	0.00795	CcSEcCtD
Bosentan—Bronchitis—Thalidomide—leprosy	0.000829	0.00784	CcSEcCtD
Bosentan—Neutropenia—Thalidomide—leprosy	0.000806	0.00763	CcSEcCtD
Bosentan—Upper respiratory tract infection—Thalidomide—leprosy	0.000802	0.00758	CcSEcCtD
Bosentan—Pollakiuria—Thalidomide—leprosy	0.000797	0.00754	CcSEcCtD
Bosentan—Weight increased—Thalidomide—leprosy	0.000785	0.00742	CcSEcCtD
Bosentan—Gastrointestinal pain—Dapsone—leprosy	0.000783	0.00741	CcSEcCtD
Bosentan—Weight decreased—Thalidomide—leprosy	0.00078	0.00738	CcSEcCtD
Bosentan—Hyperglycaemia—Thalidomide—leprosy	0.000778	0.00736	CcSEcCtD
Bosentan—Pneumonia—Thalidomide—leprosy	0.000773	0.00732	CcSEcCtD
Bosentan—Infestation NOS—Thalidomide—leprosy	0.000769	0.00727	CcSEcCtD
Bosentan—Infestation—Thalidomide—leprosy	0.000769	0.00727	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000762	0.00721	CcSEcCtD
Bosentan—Acute coronary syndrome—Thalidomide—leprosy	0.000758	0.00717	CcSEcCtD
Bosentan—Body temperature increased—Dapsone—leprosy	0.000757	0.00716	CcSEcCtD
Bosentan—Abdominal pain—Dapsone—leprosy	0.000757	0.00716	CcSEcCtD
Bosentan—Renal failure—Thalidomide—leprosy	0.000756	0.00715	CcSEcCtD
Bosentan—Myocardial infarction—Thalidomide—leprosy	0.000754	0.00713	CcSEcCtD
Bosentan—Stomatitis—Thalidomide—leprosy	0.00075	0.00709	CcSEcCtD
Bosentan—Conjunctivitis—Thalidomide—leprosy	0.000747	0.00707	CcSEcCtD
Bosentan—Haematuria—Thalidomide—leprosy	0.000733	0.00693	CcSEcCtD
Bosentan—Epistaxis—Thalidomide—leprosy	0.000725	0.00686	CcSEcCtD
Bosentan—Sinusitis—Thalidomide—leprosy	0.000721	0.00682	CcSEcCtD
Bosentan—Bradycardia—Thalidomide—leprosy	0.000703	0.00665	CcSEcCtD
Bosentan—Hepatitis—Thalidomide—leprosy	0.00069	0.00653	CcSEcCtD
Bosentan—Hypoaesthesia—Thalidomide—leprosy	0.000687	0.0065	CcSEcCtD
Bosentan—Urinary tract disorder—Thalidomide—leprosy	0.000682	0.00645	CcSEcCtD
Bosentan—Oedema peripheral—Thalidomide—leprosy	0.00068	0.00643	CcSEcCtD
Bosentan—Urethral disorder—Thalidomide—leprosy	0.000677	0.0064	CcSEcCtD
Bosentan—Erythema multiforme—Thalidomide—leprosy	0.000653	0.00617	CcSEcCtD
Bosentan—Eye disorder—Thalidomide—leprosy	0.000645	0.0061	CcSEcCtD
Bosentan—Tinnitus—Thalidomide—leprosy	0.000644	0.00609	CcSEcCtD
Bosentan—Cardiac disorder—Thalidomide—leprosy	0.000641	0.00606	CcSEcCtD
Bosentan—Angiopathy—Thalidomide—leprosy	0.000626	0.00592	CcSEcCtD
Bosentan—Immune system disorder—Thalidomide—leprosy	0.000624	0.0059	CcSEcCtD
Bosentan—Mediastinal disorder—Thalidomide—leprosy	0.000622	0.00588	CcSEcCtD
Bosentan—Chills—Thalidomide—leprosy	0.000619	0.00586	CcSEcCtD
Bosentan—Vomiting—Dapsone—leprosy	0.000609	0.00576	CcSEcCtD
Bosentan—Mental disorder—Thalidomide—leprosy	0.000605	0.00572	CcSEcCtD
Bosentan—Malnutrition—Thalidomide—leprosy	0.000601	0.00568	CcSEcCtD
Bosentan—Headache—Dapsone—leprosy	0.0006	0.00568	CcSEcCtD
Bosentan—Flatulence—Thalidomide—leprosy	0.000592	0.0056	CcSEcCtD
Bosentan—Back pain—Thalidomide—leprosy	0.000581	0.0055	CcSEcCtD
Bosentan—Muscle spasms—Thalidomide—leprosy	0.000578	0.00546	CcSEcCtD
Bosentan—Nausea—Dapsone—leprosy	0.000569	0.00538	CcSEcCtD
Bosentan—Vision blurred—Thalidomide—leprosy	0.000566	0.00536	CcSEcCtD
Bosentan—Tremor—Thalidomide—leprosy	0.000563	0.00532	CcSEcCtD
Bosentan—Anaemia—Thalidomide—leprosy	0.000555	0.00525	CcSEcCtD
Bosentan—Angioedema—Thalidomide—leprosy	0.000549	0.00519	CcSEcCtD
Bosentan—Vertigo—Thalidomide—leprosy	0.00054	0.00511	CcSEcCtD
Bosentan—Syncope—Thalidomide—leprosy	0.000539	0.0051	CcSEcCtD
Bosentan—Leukopenia—Thalidomide—leprosy	0.000538	0.00509	CcSEcCtD
Bosentan—Palpitations—Thalidomide—leprosy	0.000531	0.00502	CcSEcCtD
Bosentan—Loss of consciousness—Thalidomide—leprosy	0.000528	0.005	CcSEcCtD
Bosentan—Cough—Thalidomide—leprosy	0.000524	0.00496	CcSEcCtD
Bosentan—Arthralgia—Thalidomide—leprosy	0.000512	0.00484	CcSEcCtD
Bosentan—Chest pain—Thalidomide—leprosy	0.000512	0.00484	CcSEcCtD
Bosentan—Anxiety—Thalidomide—leprosy	0.00051	0.00482	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000508	0.00481	CcSEcCtD
Bosentan—Discomfort—Thalidomide—leprosy	0.000505	0.00478	CcSEcCtD
Bosentan—Dry mouth—Thalidomide—leprosy	0.0005	0.00473	CcSEcCtD
Bosentan—Oedema—Thalidomide—leprosy	0.00049	0.00464	CcSEcCtD
Bosentan—Infection—Thalidomide—leprosy	0.000487	0.00461	CcSEcCtD
Bosentan—Shock—Thalidomide—leprosy	0.000483	0.00456	CcSEcCtD
Bosentan—Nervous system disorder—Thalidomide—leprosy	0.000481	0.00455	CcSEcCtD
Bosentan—Thrombocytopenia—Thalidomide—leprosy	0.00048	0.00454	CcSEcCtD
Bosentan—Tachycardia—Thalidomide—leprosy	0.000479	0.00453	CcSEcCtD
Bosentan—Skin disorder—Thalidomide—leprosy	0.000476	0.00451	CcSEcCtD
Bosentan—Hyperhidrosis—Thalidomide—leprosy	0.000474	0.00448	CcSEcCtD
Bosentan—Anorexia—Thalidomide—leprosy	0.000467	0.00442	CcSEcCtD
Bosentan—Hypotension—Thalidomide—leprosy	0.000458	0.00433	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Thalidomide—leprosy	0.000447	0.00423	CcSEcCtD
Bosentan—Insomnia—Thalidomide—leprosy	0.000444	0.0042	CcSEcCtD
Bosentan—Paraesthesia—Thalidomide—leprosy	0.00044	0.00417	CcSEcCtD
Bosentan—Dyspnoea—Thalidomide—leprosy	0.000437	0.00414	CcSEcCtD
Bosentan—Somnolence—Thalidomide—leprosy	0.000436	0.00412	CcSEcCtD
Bosentan—Dyspepsia—Thalidomide—leprosy	0.000432	0.00408	CcSEcCtD
Bosentan—Decreased appetite—Thalidomide—leprosy	0.000426	0.00403	CcSEcCtD
Bosentan—Gastrointestinal disorder—Thalidomide—leprosy	0.000423	0.004	CcSEcCtD
Bosentan—Fatigue—Thalidomide—leprosy	0.000423	0.004	CcSEcCtD
Bosentan—Pain—Thalidomide—leprosy	0.000419	0.00397	CcSEcCtD
Bosentan—Constipation—Thalidomide—leprosy	0.000419	0.00397	CcSEcCtD
Bosentan—Gastrointestinal pain—Thalidomide—leprosy	0.000401	0.00379	CcSEcCtD
Bosentan—Urticaria—Thalidomide—leprosy	0.00039	0.00368	CcSEcCtD
Bosentan—Abdominal pain—Thalidomide—leprosy	0.000388	0.00367	CcSEcCtD
Bosentan—Body temperature increased—Thalidomide—leprosy	0.000388	0.00367	CcSEcCtD
Bosentan—Hypersensitivity—Thalidomide—leprosy	0.000361	0.00342	CcSEcCtD
Bosentan—Asthenia—Thalidomide—leprosy	0.000352	0.00333	CcSEcCtD
Bosentan—Pruritus—Thalidomide—leprosy	0.000347	0.00328	CcSEcCtD
Bosentan—Diarrhoea—Thalidomide—leprosy	0.000336	0.00317	CcSEcCtD
Bosentan—Dizziness—Thalidomide—leprosy	0.000324	0.00307	CcSEcCtD
Bosentan—Vomiting—Thalidomide—leprosy	0.000312	0.00295	CcSEcCtD
Bosentan—Rash—Thalidomide—leprosy	0.000309	0.00292	CcSEcCtD
Bosentan—Dermatitis—Thalidomide—leprosy	0.000309	0.00292	CcSEcCtD
Bosentan—Headache—Thalidomide—leprosy	0.000307	0.00291	CcSEcCtD
Bosentan—Nausea—Thalidomide—leprosy	0.000291	0.00276	CcSEcCtD
